P thor Straten - JoVE Visualize

Showing results (1-10 of 36) with videos related to

Pageof 4

Sort By:

Cancer Immunology, Immunotherapy : CII|May 1, 1996

Differential modulation by interferon gamma of the sensitivity of human melanoma cells to cytolytic T cell clones that recognize differentiation or progression antigensA F Kirkin, P thor Straten, J Zeuthen

Cancer Immunology, Immunotherapy : CII|September 29, 1999

In situ T cells in melanomaP thor Straten, J C Becker, P Guldberg, et al.

International Journal of Cancer|March 4, 1997

Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell linesP Thor Straten, A F Kirkin, T Seremet, et al.

International Journal of Cancer|January 2, 1994

Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomasP Thor Straten, J Schøller, K Hou-Jensen, et al.

Cancer Immunology, Immunotherapy : CII|September 29, 1999

Function and dysfunction of CD4(+) T cells in the immune response to melanomaW H Fischer, P thor Straten, P Terheyden, et al.

FEBS Letters|August 4, 1998

Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomasK N Dzhandzhugazyan, A F Kirkin, P thor Straten, et al.

The Journal of Clinical Investigation|July 15, 1996

Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanomaP thor Straten, J C Becker, T Seremet, et al.

Biotechniques|August 26, 1998

Detection and characterization of alpha-beta-T-cell clonality by denaturing gradient gel electrophoresis (DGGE)P thor Straten, A Barfoed, T Seremet, et al.

European Journal of Immunology|February 13, 2001

Differential expression of CD28 and CD94/NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph nodeJ C Becker, C S Vetter, D Schrama, et al.

Cancer Research|September 1, 1997

Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanomaP Guldberg, P thor Straten, A Birck, et al.

Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:

Pageof 4

Cancer Immunology, Immunotherapy : CII|May 1, 1996

Differential modulation by interferon gamma of the sensitivity of human melanoma cells to cytolytic T cell clones that recognize differentiation or progression antigensA F Kirkin, P thor Straten, J Zeuthen

Cancer Immunology, Immunotherapy : CII|September 29, 1999

In situ T cells in melanomaP thor Straten, J C Becker, P Guldberg, et al.

International Journal of Cancer|March 4, 1997

Expression of transporter associated with antigen processing 1 and 2 (TAP1/2) in malignant melanoma cell linesP Thor Straten, A F Kirkin, T Seremet, et al.

International Journal of Cancer|January 2, 1994

Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomasP Thor Straten, J Schøller, K Hou-Jensen, et al.

Cancer Immunology, Immunotherapy : CII|September 29, 1999

Function and dysfunction of CD4(+) T cells in the immune response to melanomaW H Fischer, P thor Straten, P Terheyden, et al.

FEBS Letters|August 4, 1998

Ecto-ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomasK N Dzhandzhugazyan, A F Kirkin, P thor Straten, et al.

The Journal of Clinical Investigation|July 15, 1996

Clonal T cell responses in tumor infiltrating lymphocytes from both regressive and progressive regions of primary human malignant melanomaP thor Straten, J C Becker, T Seremet, et al.

Biotechniques|August 26, 1998

Detection and characterization of alpha-beta-T-cell clonality by denaturing gradient gel electrophoresis (DGGE)P thor Straten, A Barfoed, T Seremet, et al.

European Journal of Immunology|February 13, 2001

Differential expression of CD28 and CD94/NKG2 on T cells with identical TCR beta variable regions in primary melanoma and sentinel lymph nodeJ C Becker, C S Vetter, D Schrama, et al.

Cancer Research|September 1, 1997

Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanomaP Guldberg, P thor Straten, A Birck, et al.

Pageof 4